Symbol="STRO"
AssetType="Common Stock"
Name="Sutro Biopharma"
Description="Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California."
CIK="1382101"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="265834000"
EBITDA="-126070000"
PERatio="None"
PEGRatio="None"
BookValue="3.082"
DividendPerShare="0"
DividendYield="0"
EPS="-2.17"
RevenuePerShareTTM="1.386"
ProfitMargin="-1.746"
OperatingMarginTTM="-1.771"
ReturnOnAssetsTTM="-0.249"
ReturnOnEquityTTM="-0.641"
RevenueTTM="74549000"
GrossProfitTTM="-42520000"
DilutedEPSTTM="-2.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.149"
AnalystTargetPrice="18.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.05"
PriceToBookRatio="1.876"
EVToRevenue="2.289"
EVToEBITDA="-1.451"
Beta="0.874"
num_52WeekHigh="8.72"
num_52WeekLow="4.09"
num_50DayMovingAverage="4.845"
num_200DayMovingAverage="5.94"
SharesOutstanding="60417000"
DividendDate="None"
ExDividendDate="None"
symbol="STRO"
open="4.37"
high="4.47"
low="4.30"
price="4.40"
volume="157880.00"
latest_trading_day="2023-08-04"
previous_close="4.34"
change="0.06"
change_percent="1.3825%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="54"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="485672"
Change_recent_avg="-0.01"
Delta_recent_avg="0.31"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="1147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_negative_thumbnail_id_2="1134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
